Search Results for: ali

Name Synonyms Targets Target Pathway PubCHEM Datatset Sample size Screening site
Alisertib MLN8237 AURKA Mitosis GDSC1 891 MGH
Alisertib MLN8237 AURKA Mitosis 24771867 GDSC2 949 SANGER
Idelalisib CAL-101, Zydelig PI3Kdelta PI3K/MTOR signaling 11625818 GDSC1 914 MGH
Lenalidomide CDC-501, CC-5013, Revlimid CRBN Protein stability and degradation 216326 GDSC1 933 SANGER
Lenalidomide CDC-501, CC-5013, Revlimid CRBN Protein stability and degradation 216326 GDSC2 949 SANGER
Omipalisib GSK2126458, GSK-2126458, EX-8678, GSK458 PI3K (class 1), MTORC1, MTORC2 PI3K/MTOR signaling 25167777 GDSC1 914 MGH
Oxaliplatin Eloxatin DNA alkylating agent DNA replication 5310940 GDSC2 967 SANGER
Oxaliplatin DNA alkylating agent DNA replication GDSC2 717 SANGER
Pilaralisib XL-147 PI3K PI3K/MTOR signaling GDSC1 919 MGH
Tretinoin ATRA, Vesanoid, Renova, Atralin, Tretin-X, Avita Retinoic acid Other 444795 GDSC1 923 SANGER
Tretinoin ATRA, Vesanoid, Renova, Atralin, Tretin-X, Avita Retinoic acid Other 444795 GDSC2 225 SANGER
Voxtalisib XL-765, SAR245409 PI3K (class 1), DNAPK, MTOR PI3K/MTOR signaling GDSC1 919 MGH
Feature Name Feature Type
cnaLIHC10 copy number alteration (loss)
cnaLIHC7 copy number alteration (loss)

Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.